Endonovo Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Collier Alan Brian, was filed 07 Jul 2020.
Endonovo Therapeutics, Inc.: what insiders have been doing
This page follows insider dealings at Endonovo Therapeutics, Inc. as filed with SEC (Form 4). No insider at Endonovo Therapeutics, Inc. has published a filing in the past twelve months. The most recent one dates from 7 July 2020.
Looking back to 2015, when coverage begins, insiders filed 3,458 purchases and no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- -61.5%Entry US$0.09 · Close at T+365 US$0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
- 200 shares@ US$0.10351.3% of flowCommon StockSEC:0001645470-20-000005:0Canonical exit: 28 Sept 2020 (T+90)
- 100 shares@ US$0.10040.7% of flowCommon StockSEC:0001645470-20-000005:1Canonical exit: 29 Sept 2020 (T+90)
- 100 shares@ US$0.10240.7% of flowCommon StockSEC:0001645470-20-000005:2Canonical exit: 29 Sept 2020 (T+90)
- 100 shares@ US$0.96490.8% of flowCommon StockSEC:0001645470-20-000004:0Canonical exit: 22 May 2020 (T+90)
- 100 shares@ US$1.500.2% of flowCommon StockSEC:0001645470-20-000002:6Canonical exit: 19 Mar 2020 (T+90)
- 100 shares@ US$2.250.3% of flowCommon StockSEC:0001645470-20-000001:0Canonical exit: 29 Mar 2020 (T+90)
- 100 shares@ US$1.750.2% of flowCommon StockSEC:0001645470-20-000001:1Canonical exit: 1 Apr 2020 (T+90)
- 2,000 shares@ US$0.00280.0% of flowCommon StockSEC:0001645470-19-000057:0Canonical exit: 9 Mar 2020 (T+90)
- 1,000 shares@ US$0.00250.0% of flowCommon StockSEC:0001645470-19-000057:1Canonical exit: 9 Mar 2020 (T+90)
- 1,000 shares@ US$0.0020.0% of flowCommon StockSEC:0001645470-19-000057:2Canonical exit: 10 Mar 2020 (T+90)
- 100 shares@ US$0.00190.0% of flowCommon StockSEC:0001645470-19-000057:3Canonical exit: 10 Mar 2020 (T+90)
- 1,000 shares@ US$0.00220.0% of flowCommon StockSEC:0001645470-19-000057:4Canonical exit: 11 Mar 2020 (T+90)
- 500 shares@ US$0.00150.0% of flowCommon StockSEC:0001645470-19-000057:5Canonical exit: 15 Mar 2020 (T+90)
- 100 shares@ US$0.00150.0% of flowCommon StockSEC:0001645470-19-000057:6Canonical exit: 19 Mar 2020 (T+90)
- 2,000 shares@ US$0.00350.0% of flowCommon StockSEC:0001645470-19-000056:0Canonical exit: 23 Feb 2020 (T+90)
- 1,000 shares@ US$0.00350.0% of flowCommon StockSEC:0001645470-19-000056:1Canonical exit: 25 Feb 2020 (T+90)
- 2,000 shares@ US$0.00350.0% of flowCommon StockSEC:0001645470-19-000056:2Canonical exit: 25 Feb 2020 (T+90)
- 2,000 shares@ US$0.00290.0% of flowCommon StockSEC:0001645470-19-000056:3Canonical exit: 27 Feb 2020 (T+90)
- 2,000 shares@ US$0.00290.0% of flowCommon StockSEC:0001645470-19-000056:4Canonical exit: 1 Mar 2020 (T+90)
- 2,000 shares@ US$0.00290.0% of flowCommon StockSEC:0001645470-19-000056:5Canonical exit: 3 Mar 2020 (T+90)
- 2,000 shares@ US$0.00280.0% of flowCommon StockSEC:0001645470-19-000056:7Canonical exit: 4 Mar 2020 (T+90)
- 1,000 shares@ US$0.00370.0% of flowCommon StockSEC:0001645470-19-000055:0Canonical exit: 18 Feb 2020 (T+90)
- 1,000 shares@ US$0.00380.0% of flowCommon StockSEC:0001645470-19-000055:1Canonical exit: 20 Feb 2020 (T+90)
- 2,000 shares@ US$0.00710.0% of flowCommon stockSEC:0001645470-19-000054:0Canonical exit: 9 Feb 2020 (T+90)
- 200 shares@ US$0.00950.0% of flowCommon StockSEC:0001645470-19-000053:0Canonical exit: 15 Jan 2020 (T+90)
25 of 3458 declarations
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. is a company focused on developing innovative therapies for pain management and inflammatory diseases. It is listed on the NASDAQ.
